antibody deficiency disease

an·ti·bod·y de·fi·cien·cy syn·drome

any of a group of disorders associated with a defective antibody production resulting from defects in the B-type lymphocyte system or in T-type lymphocytes; the chief manifestation is an increased susceptibility to infection by various microorganisms. See: agammaglobulinemia, hypogammaglobulinemia, immunodeficiency.

antibody deficiency disease

A nonspecific term for any B-cell immunodeficiency
References in periodicals archive ?
Key factors driving the market growth include approvals for IVIG therapy from FDA, EMA, and government, increase in awareness about IVIG treatment, rise in incidence of antibody deficiency diseases & hemophilic patients, and emergence of technologically advanced IVIG products.